Arsenic Trioxide Reactivates Proteasome-Dependent Degradation of Mutant p53 Protein in Cancer Cells in Part via Enhanced Expression of Pirh2 E3 Ligase

Open Access

Peer-reviewed

Research Article

Wensheng Yan,

Affiliation Comparative Oncology Laboratory, School of Medicine and Veterinary Medicine, University of California at Davis, Davis, California, United States of America
⨯
Yong-Sam Jung,

Affiliation Comparative Oncology Laboratory, School of Medicine and Veterinary Medicine, University of California at Davis, Davis, California, United States of America
⨯
Yanhong Zhang,

Affiliation Comparative Oncology Laboratory, School of Medicine and Veterinary Medicine, University of California at Davis, Davis, California, United States of America
⨯
Xinbin Chen

* E-mail: xbchen@ucdavis.edu

Affiliation Comparative Oncology Laboratory, School of Medicine and Veterinary Medicine, University of California at Davis, Davis, California, United States of America
⨯

Reader Comments (0)

Ligases
Is the Subject Area "Ligases" applicable to this article?

Thanks for your feedback.
Arsenic
Is the Subject Area "Arsenic" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Immunoprecipitation
Is the Subject Area "Immunoprecipitation" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Proteasomes
Is the Subject Area "Proteasomes" applicable to this article?

Thanks for your feedback.